Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2,527,521,347
-
Number of holders
-
3,429
-
Total 13F shares, excl. options
-
1,909,828,089
-
Shares change
-
-44,857,165
-
Total reported value, excl. options
-
$216,776,477,378
-
Value change
-
-$5,513,627,792
-
Put/Call ratio
-
91%
-
Number of buys
-
1,591
-
Number of sells
-
-1,554
-
Price
-
$113.56
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q3 2024
3,700 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q3 2024.
Merck & Co., Inc. - Common Stock (MRK) has 3,429 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,909,828,089 shares
of 2,527,521,347 outstanding shares and own 76% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (249,803,915 shares), BlackRock, Inc. (212,059,737 shares), STATE STREET CORP (119,026,412 shares), WELLINGTON MANAGEMENT GROUP LLP (75,809,383 shares), GEODE CAPITAL MANAGEMENT, LLC (59,155,004 shares), FMR LLC (49,706,304 shares), MORGAN STANLEY (44,391,822 shares), BANK OF AMERICA CORP /DE/ (38,868,024 shares), NORGES BANK (33,781,024 shares), and JPMORGAN CHASE & CO (27,285,865 shares).
This table shows the top 3,429 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.